Ho Jung An

2.8k total citations
90 papers, 1.2k citations indexed

About

Ho Jung An is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Ho Jung An has authored 90 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 33 papers in Pulmonary and Respiratory Medicine and 18 papers in Surgery. Recurrent topics in Ho Jung An's work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (10 papers) and Gastric Cancer Management and Outcomes (9 papers). Ho Jung An is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (10 papers) and Gastric Cancer Management and Outcomes (9 papers). Ho Jung An collaborates with scholars based in South Korea, United States and China. Ho Jung An's co-authors include Yoon Ho Ko, Hye Sung Won, Myung‐Ju Ahn, Eun Joo Kang, Keon Uk Park, Se‐Hoon Lee, Keunchil Park, Jin Seok Ahn, Chan Kim and Hong Jae Chon and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Scientific Reports.

In The Last Decade

Ho Jung An

84 papers receiving 1.2k citations

Peers

Countries citing papers authored by Ho Jung An

Since Specialization

Citations

This map shows the geographic impact of Ho Jung An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ho Jung An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ho Jung An more than expected).

Fields of papers citing papers by Ho Jung An

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ho Jung An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ho Jung An. The network helps show where Ho Jung An may publish in the future.

Co-authorship network of co-authors of Ho Jung An

This figure shows the co-authorship network connecting the top 25 collaborators of Ho Jung An. A scholar is included among the top collaborators of Ho Jung An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ho Jung An. Ho Jung An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Barriers to Clinical Trial Enrollment: KCSG Survey-Based Perspectives of Medical Oncologists, Patients, and Their Caregivers 2025 ·Cancer Research and Treatment ·Chi Hoon Maeng, Inkeun Park, (unknown), Ho Jung An, Hyun Jeong Shim, Sang‐Cheol Lee	0
2	Real-World Comparison of Trifluridine–Tipiracil with or Without Bevacizumab in Patients with Refractory Metastatic Colorectal Cancer 2025 ·Biomedicines ·Hyunho Kim, (unknown), Ho Jung An, In Ho Kim, (unknown), Yoon Suk Lee, In Kyu Lee, Myung Ah Lee, Se Jun Park	0
3	Common Cancer-Related Factors and the Risk of Developing Kaposi Sarcoma in Individuals without AIDS: Korea National Health Insurance Services Claims Database 2024 ·Journal of Clinical Medicine ·(unknown), Kyungdo Han, Ho Jung An, Hyung Soon Park, Byoung Yong Shim, Hyunho Kim	0
4	A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial 2023 ·Cancer Research and Treatment ·(unknown), Sun Min Lim, Hee Kyung Ahn, Yun‐Gyoo Lee, Keun-Wook Lee, Myung‐Ju Ahn, Bhumsuk Keam, Hye Ryun Kim, Hyun Woo Lee, Ho Jung An, Jin-Soo Kim	4
5	A Randomized Phase III Study of Patients With Advanced Gastric Adenocarcinoma Without Progression After Six Cycles of XELOX (Capecitabine Plus Oxaliplatin) Followed by Capecitabine Maintenance or Clinical Observation 2023 ·Journal of the Korean Gastric Cancer Association ·(unknown), Hyunho Kim, (unknown), Hyung Soon Park, Ho Jung An, In Sook Woo, Jae Ho Byun, Ji Hyung Hong, Yoon Ho Ko, Der Sheng Sun, Hye Sung Won, Jong‐Youl Jin, (unknown), In‐Ho Kim, (unknown), Byoung Yong Shim	2
6	Clinical Outcomes of Upfront Primary Tumor Resection in Synchronous Unresectable Metastatic Colorectal Cancer 2023 ·Cancers ·(unknown), Ho Jung An, Byoung Yong Shim, Hyunho Kim, Hyung Soon Park, Hyeon‐Min Cho, Bong‐Hyeon Kye, Ri Na Yoo, (unknown), Sung Hwan Kim, Jonghoon Lee, (unknown), Ji‐Han Jung, Kang‐Moon Lee, Ji Min Lee	1
7	Plasma tumor mutation burden is associated with clinical benefit in patients with non-small cell lung cancer treated with anti-programmed death-1 monotherapy 2022 ·Therapeutic Advances in Medical Oncology ·Jii Bum Lee, Hyung Soon Park, Su Jin Choi, Seong Gu Heo, Ho Jung An, Hye Ryun Kim, Min Hee Hong, Sun Min Lim, Kyle Chang, Katie Quinn, Justin I. Odegaard, Byoung Yong Shim, Byoung Chul Cho	3
8	A Phase II Study of Nivolumab plus Gemcitabine in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma (KCSG HN17–11) 2022 ·Clinical Cancer Research ·Hyun Ae Jung, Keon Uk Park, Sang‐Hee Cho, Jinyeong Lim, Keun‐Wook Lee, Min Hee Hong, Tak Yun, Ho Jung An, Woong‐Yang Park, Sérgio Pereira, Chan‐Young Ock, Bhumsuk Keam	18
9	Discussing POLST-facilitated hospice care enrollment in patients with terminal cancer 2022 ·Supportive Care in Cancer ·Ho Jung An, Hyun Jeong Jeon, Sang Hoon Chun, Hyun Ae Jung, Hee Kyung Ahn, Kyung Hee Lee, Min Ho Kim, Ju Hee Kim, Jaekyung Cheon, Su‐Jin Koh	2
10	Elevated serum substance P level as a predictive marker for moderately emetogenic chemotherapy‐induced nausea and vomiting: A prospective cohort study 2020 ·Cancer Medicine ·Hyung Soon Park, Hye Sung Won, Ho Jung An, (unknown), Hyun Ho Kim, Der Sheng Sun, Yoon Ho Ko, Byoung Yong Shim	10
11	Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12 2020 ·Journal of Cancer Research and Clinical Oncology ·Ji Hyun Park, Sang Hoon Chun, Yun‐Gyoo Lee, Hyun Chang, Keun‐Wook Lee, Hye Ryun Kim, Seong Hoon Shin, Ho Jung An, Kyoung Eun Lee, In Gyu Hwang, Myung‐Ju Ahn, Sung‐Bae Kim, Bhumsuk Keam	14
12	OA10.05 An Open-Label, Multicenter, Phase II Single Arm Trial of Osimertinib in NSCLC Patients with Uncommon EGFR Mutation(KCSG-LU15-09) 2018 ·Journal of Thoracic Oncology ·(unknown), Jong‐Mu Sun, (unknown), Jin Seok Ahn, K. Park, (unknown), Eun Joo Kang, Yoon Hee Choi, Kyae Hyung Kim, Ho Jung An, Hyun Woo Lee, Myung‐Ju Ahn	12
13	Ramosetron versus palonosetron in combination with aprepitant and dexamethasone for the control of highly emetogenic chemotherapy-induced nausea and vomiting 2018 ·Annals of Oncology ·Jung Hye Kwon, Jin Hyoung Kang, (unknown), (unknown), Ho Jung An, Joohyuk Sohn, Young Mi Seol, (unknown), Hwan‐Jung Yun, Jin Seok Ahn, (unknown)	1
14	MA16.05 For EGFR Mutant Non-Small Cell Lung Cancer, Treatment Sequence Matters? 2017 ·Journal of Thoracic Oncology ·Ho Jung An, (unknown), Sook Hee Hong, Young Kyoon Kim, Seung Joon Kim, Kyo Young Lee, Jin Hyoung Kang	1
15	Experience of Advance Directives in a Hospice Center 2015 ·Journal of Korean Medical Science ·(unknown), Ho Jung An, (unknown), (unknown), (unknown), Jung Eun Lee, (unknown), (unknown), (unknown), Hoon-Kyo Kim	11
16	Nebulized Morphine for Intractable Cough in Advanced Cancer: Two Case Reports 2015 ·Journal of Palliative Medicine ·Ho Jung An, Il‐Kyu Kim, Jung Eun Lee, Yijin Kang, Chi Hong Kim, Hoon-Kyo Kim	2
17	A Study on the Effects of the Electro-Acupuncture(EA) Stimulation after Global Ischemia(GI) on Changes in Bax and Caspase-3 Expression among Forebrain Apoptosis 2010 ·Jung‐Hyun Choi, (unknown), Jong‐Il Kim, Dong‐Il Kim, Sang Bin Lee, Ho Jung An, (unknown), (unknown), Bo-Kyoung Kim, (unknown)	1
18	The Impact of Functional Electrical Stimulus and Proprioceptive Neuromuscular Facilitation to Scapula Adductor on Upper Limb Functions and Gait of the Patients with Stroke 2010 ·(unknown), (unknown), Sang Soo Kim, Ho Jung An, (unknown), (unknown), (unknown), Bo Kyoung Kim, Sung Ho Kim, (unknown), (unknown)	4
19	The Effects of Interferential Current and Kaltenborn-Evjenth Orthopedic Manual Therapy on Functional Constipation 2010 ·(unknown), Ho Jung An, (unknown), Ji Hwan Park, Suhn-Yeop Kim, (unknown), (unknown), (unknown), (unknown)	1
20	Study on the History of Korean Physical Therapy 2010 ·Sang Bin Lee, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ho Jung An	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact